Taiwan FDA registration 6fc4925c0288178f3778524454cb57b2
"Siemens Atellica" Apolipoprotein A-1 (APO A1) (Non-Sterile)
TW: “西門子”脂蛋白元A-1試驗試劑 (未滅菌)
Taiwan·Risk Class 1·MD·RANDOX LABORATORIES LIMITED·Registered Sep 13, 2018 – Sep 13, 2028ActiveRegistration details
- Analysis ID
- 6fc4925c0288178f3778524454cb57b2
- License Form
- Ministry of Health Medical Device Import No. 019601
- Customs Code
- DHA09401960101
Company information
- Manufacturer
- RANDOX LABORATORIES LIMITED
- Manufacturer Country
- United Kingdom
- Authorized Representative
- SIEMENS HEALTHCARE LIMITED
Product details
- Intended Use
- Limited to the first level recognition range of the lipoprotein test system (A.1475) of the medical device management method.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1475 Lipoprotein Testing System
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Sep 13, 2018
- Expiry Date
- Sep 13, 2028
About this record
Access comprehensive regulatory information for "Siemens Atellica" Apolipoprotein A-1 (APO A1) (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 6fc4925c0288178f3778524454cb57b2 and manufactured by RANDOX LABORATORIES LIMITED. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices